Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

O. Dauwalder, L. Landrieve, F. Laurent, M. de Montclos, F
Laboratory diagnosis and biosafety issues of biological warfare agents
Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.
Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,
L. Boyanova  Clinical Microbiology and Infection 
G. Catho, S. Couraud, S. Grard, A. Bouaziz, A. Sénéchal, F. Valour, T
Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992–2003  B.J.M. Vlaminckx,
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Where does a Staphylococcus aureus vaccine stand?
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain  A. Doménech-Sánchez  Clinical Microbiology.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Non-antibiotic strategies for sepsis
An eye-catching acanthocephalan
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Potential risk factors for infection with Candida spp
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
Vector control: a cornerstone in the malaria elimination campaign
G. Sakoulas  Clinical Microbiology and Infection 
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective.
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
The practice of travel medicine in Europe
Systematic review of antibiotic consumption in acute care hospitals
Update on antifungal resistance in Aspergillus and Candida
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Current experience in treating invasive zygomycosis with posaconazole
Fibronectin concentrations in catheter sepsis
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
O. Dauwalder, L. Landrieve, F. Laurent, M. de Montclos, F
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection  M. Croze, O. Dauwalder, O. Dumitrescu,
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas, T. Perpoint, G. Lina, G. Monneret, I. Mohammedi, C. Chidiac, D. Peyramond, F. Vandenesch, J. Etienne  Clinical Microbiology and Infection  Volume 14, Issue 6, Pages 546-554 (June 2008) DOI: 10.1111/j.1469-0691.2008.01975.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Vβ repertoire of two patients with menstrual toxic shock syndrome (TSS), two patients with non-menstrual TSS, and two patients with septic shock. The data reveal a superantigenic toxin Vβ signature during TSS, but not during septic shock. *, Vβ expansion of more than two standard deviations above that of the controls; *, Vβ expansion of less than two standard deviations above that of the controls, but with >1.5-fold variation of a Vβ subset between two time-points. NA, data not available; TSST-1, toxic shock syndrome toxin-1; SE, staphylococcal enterotoxin. Clinical Microbiology and Infection 2008 14, 546-554DOI: (10.1111/j.1469-0691.2008.01975.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions